Michael J. Yang insider trades
Open-market stock purchases and sales by Michael J. Yang, Director at Ionis Pharmaceuticals Inc, from SEC Form 4 filings since Mar 29, 2017.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +76%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jul 1, 2026 | IONS Ionis Pharmaceuticals Inc | Bought (not open market) | — |
| Jul 1, 2026 | IONS Ionis Pharmaceuticals Inc | Bought (not open market) | — |
| Jun 10, 2026 | PCRX Pacira BioSciences, Inc | Bought (not open market) | — |
| Jun 10, 2026 | PCRX Pacira BioSciences, Inc | Bought (not open market) | — |
| Jan 15, 2026 | IONS Ionis Pharmaceuticals Inc | Bought (not open market) | — |